GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (XTER:JNJ) » Definitions » Marketable Securities

Johnson & Johnson (XTER:JNJ) Marketable Securities : €286 Mil (As of Sep. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Johnson & Johnson Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Johnson & Johnson's Marketable Securities for the quarter that ended in Sep. 2024 was €286 Mil.

Johnson & Johnson's annual Marketable Securities declined from Dec. 2021 (€15,152 Mil) to Dec. 2022 (€8,866 Mil) and declined from Dec. 2022 (€8,866 Mil) to Dec. 2023 (€979 Mil).

Johnson & Johnson Marketable Securities Historical Data

The historical data trend for Johnson & Johnson's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Marketable Securities Chart

Johnson & Johnson Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,783.80 9,206.40 15,152.09 8,866.05 979.36

Johnson & Johnson Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,544.67 979.36 685.40 554.61 285.62

Johnson & Johnson Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Johnson & Johnson  (XTER:JNJ) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Johnson & Johnson Marketable Securities Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Johnson & Johnson Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (XTER:JNJ) » Definitions » Marketable Securities
Comparable Companies
ABBV MRK AMGN PFE BMY GILD LLY BIIB OGN AMRN OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN XPAR:SAN LSE:GSK TSE:4519 TSE:4568 SHSE:600276 TSE:4578
Traded in Other Exchanges
JNJ:USA JNJ:Peru JNJ:Mexico JNJ_KZ:Kazakhstan 1JNJ:Italy JNJd:UK JNJ0:Germany JNJ:Germany JNJ:Germany JNJ:Germany JNJ:Canada JNJB34:Brazil JNJ:Bulgaria JNJ:Austria JNJ:Argentina
Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Website
https://www.jnj.com
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.